相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum and gene expression profile of cytokines in first-episode psychosis
Marco Di Nicola et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Chemokines in bipolar disorder: Trait or state?
Izabela Guimaraes Barbosa et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample
Nora Hamdani et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia
George Anderson et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Neurodevelopment and inflammatory patterns in schizophrenia in relation to pathophysiology
A. Carlo Altamura et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Schizophrenia: Metabolic aspects of aetiology, diagnosis and future treatment strategies
Laura W. Harris et al.
PSYCHONEUROENDOCRINOLOGY (2013)
The Relationship Between Toxoplasma Gondii Infection and Mood Disorders in the Third National Health and Nutrition Survey
Brad D. Pearce et al.
BIOLOGICAL PSYCHIATRY (2012)
Neuroprogression in bipolar disorder
Marguerite Reid Schneider et al.
BIPOLAR DISORDERS (2012)
Minocycline Therapeutic Potential in Psychiatry
Olivia M. Dean et al.
CNS DRUGS (2012)
Monocyte chemoattractant protein-1 in schizophrenia: -2518A/G genetic variant and protein levels in Armenian population
Roksana Zakharyan et al.
CYTOKINE (2012)
Nitric oxide in patients with schizophrenia: the relationship with the severity of illness and the antipsychotic treatment
Giuseppe Minutolo et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Plasma cortisol in first episode drug-naive mania: Differential levels in euphoric versus irritable mood
Leandro L. Valiengo et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
Imran B. Chaudhry et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia
Xiang Yang Zhang et al.
NEUROPHARMACOLOGY (2012)
Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study
Massimiliano Buoli et al.
PSYCHIATRY INVESTIGATION (2012)
Differential age- and disease-related effects on the expression of genes related to the arachidonic acid signaling pathway in schizophrenia
Bin Tang et al.
PSYCHIATRY RESEARCH (2012)
Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome
Wouter Beumer et al.
PSYCHONEUROENDOCRINOLOGY (2012)
A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia
W. J. M. van der Kemp et al.
SCHIZOPHRENIA RESEARCH (2012)
Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View
Jeffrey K. Yao et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Brian J. Miller et al.
BIOLOGICAL PSYCHIATRY (2011)
Neonatal antibodies to infectious agents and risk of bipolar disorder: a population-based case-control study
Preben Bo Mortensen et al.
BIPOLAR DISORDERS (2011)
Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls
Marcella Reale et al.
BMC NEUROSCIENCE (2011)
The activation of monocyte and T cell networks in patients with bipolar disorder
Roosmarijn C. Drexhage et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Kynurenine Pathway in Schizophrenia: Pathophysiological and Therapeutic Aspects
Norbert Mueller et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
White matter neuron alterations in schizophrenia and related disorders
Caroline M. Connor et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2011)
3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia
Ruth Condray et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Peripheral biomarkers and illness activity in bipolar disorder
Flavio Kapczinski et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2011)
Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia
Sigrun Hope et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2011)
Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients
H-W Kim et al.
MOLECULAR PSYCHIATRY (2011)
Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors
M. Berk et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond
Urs Meyer et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders
Raouf Igue et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance
Mauricio Kunz et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2011)
Duration of illness and duration of untreated illness in relation to drug response in psychiatric disorders
Alfredo Carlo Altamura et al.
NEUROPSYCHIATRY (2011)
Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
Alan S. Brown et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity
Johann Steiner et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2010)
The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder
Roosmarijn C. Drexhage et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders: Results From a Randomized, Double-Blind, Placebo-Controlled Trial
Wijnand Laan et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Brain lipid concentrations in bipolar disorder
Miki Igarashi et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients
J. S. Rao et al.
MOLECULAR PSYCHIATRY (2010)
Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia
J. K. Yao et al.
MOLECULAR PSYCHIATRY (2010)
The MCP-1 Gene (SCYA2) and Mood Disorders: Preliminary Results of a Case-Control Association Study
A. Carlo Altamura et al.
NEUROIMMUNOMODULATION (2010)
Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder
Pieter Stolk et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2010)
Cytokine hypothesis of schizophrenia pathogenesis: Evidence from human studies and animal models
Yuichiro Watanabe et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2010)
Serum bilirubin levels and UGT1A1 promoter variations in patients with schizophrenia
Libor Vitek et al.
PSYCHIATRY RESEARCH (2010)
Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
Norbert Mueller et al.
SCHIZOPHRENIA RESEARCH (2010)
The association of infectious agents and schizophrenia
Daniela Krause et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
Genetic and Environmental Influences on Pro-Inflammatory Monocytes in Bipolar Disorder A Twin Study
Roos C. Padmos et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Immune involvement in schizophrenia and autism: Etiology, pathology and animal models
Paul H. Patterson
BEHAVIOURAL BRAIN RESEARCH (2009)
Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder
Elisa Brietzke et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
Elisa Brietzke et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder: A Systematic Review of the Literature
Benjamin I. Goldstein et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Cytokine Changes and Tryptophan Metabolites in Medication-Naive and Medication-Free Schizophrenic Patients
Yong-Ku Kim et al.
NEUROPSYCHOBIOLOGY (2009)
Oxidative imbalance in bipolar disorder subtypes: A comparative study
Mehmet Yumru et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients
Monia Raffa et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Cytokines and schizophrenia: Microglia hypothesis of schizophrenia
Akira Monji et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2009)
Schizophrenia: From the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers
Gerald Stoeber et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2009)
A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes
Roos C. Padmos et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review
Stephane Potvin et al.
BIOLOGICAL PSYCHIATRY (2008)
Prenatal stress, fetal imprinting and immunity
E. Merlot et al.
BRAIN BEHAVIOR AND IMMUNITY (2008)
Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide
Johann Steiner et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Association of tumor necrosis factor-308G/A promoter polymorphism with schizophrenia and bipolar affective disorder in a Polish population
Piotr M. Czerski et al.
NEUROPSYCHOBIOLOGY (2008)
Increased serum levels of CCL11/eotaxin in schizophrenia
Antonio Lucio Teixeira et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder
Robert K. McNamara et al.
PSYCHIATRY RESEARCH (2008)
The role of pro-inflammatory factors in mediating the effects on the fetus of prenatal undernutrition: Implications for schizophrenia
Q. Shen et al.
SCHIZOPHRENIA RESEARCH (2008)
Cytokines and Myelination in the Central Nervous System
Thomas Schmitz et al.
THESCIENTIFICWORLDJOURNAL (2008)
Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
Yong-Ku Kim et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
The effects of maternal inflammation on neuronal development: possible mechanisms
G. Miller Jonakait
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2007)
Immune variations in bipolar disorder:: phasic differences
Abigail Ortiz-Dominguez et al.
BIPOLAR DISORDERS (2007)
Tryptophan breakdown pathway in bipolar mania
Aye Mu Myint et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder?
Ronald Vonk et al.
BIOLOGICAL PSYCHIATRY (2007)
Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease - there is no schizoaffective disorder
Charles Ray Lake et al.
CURRENT OPINION IN PSYCHIATRY (2007)
C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia
Faith Dickerson et al.
SCHIZOPHRENIA RESEARCH (2007)
Association study between the corticotropin-releasing hormone receptor 2 gene and suicidality in bipolar disorder
Vincenzo De Luca et al.
EUROPEAN PSYCHIATRY (2007)
Antibodies to Toxoplasma gondii in patients with schizophrenia:: A meta-analysis
E. Fuller Torrey et al.
SCHIZOPHRENIA BULLETIN (2007)
Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia
Xiaoduo Fan et al.
PSYCHIATRY RESEARCH (2007)
Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring:: Implications for schizophrenia
M. Nyffeler et al.
NEUROSCIENCE (2006)
PhenoChipping of psychotic disorders: A novel approach for deconstructing and quantitating psychiatric phenotypes
Alexander B. Niculescu et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2006)
An autoimmune or an inflammatory process in patients with schizophrenia, schizoaffective disorder, and in their biological relatives
SOV Nunes et al.
SCHIZOPHRENIA RESEARCH (2006)
Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence
LJ Robinson et al.
BIPOLAR DISORDERS (2006)
Cytokine profiles in bipolar affective disorder: Focus on acutely ill patients
SM O'Brien et al.
JOURNAL OF AFFECTIVE DISORDERS (2006)
Elucidating the early signal transduction pathways leading to fetal brain injury in preterm birth
MA Elovitz et al.
PEDIATRIC RESEARCH (2006)
Cytokines sing the blues: inflammation and the pathogenesis of depression
CL Raison et al.
TRENDS IN IMMUNOLOGY (2006)
Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor α and interleukin-6
M Kubera et al.
PSYCHIATRY RESEARCH (2005)
Cytokines and major depression
OJG Schiepers et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Prenatal origins of individual variation in behavior and immunity
CL Coe et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
MCP-1 gene (SCYA2) and schizophrenia:: A case-control association study
E Mundo et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2005)
Evidence for a role of the arachidonic acid cascade in affective disorders: a review
ME Sublette et al.
BIPOLAR DISORDERS (2004)
Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder
S Papiol et al.
JOURNAL OF MEDICAL GENETICS (2004)
Evidence of basal pituitary-ad renal overactivity in first episode, drug naive patients with schizophrenia
MCM Ryan et al.
PSYCHONEUROENDOCRINOLOGY (2004)
Impact of IL-1 receptor antagonist gene polymorphism on schizophrenia and bipolar disorder
SJ Kim et al.
PSYCHIATRIC GENETICS (2004)
Acute stress effects on local Il-1β responses to pathogens in a human in vivo model
R Deinzer et al.
BRAIN BEHAVIOR AND IMMUNITY (2004)
A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder
RM Murray et al.
SCHIZOPHRENIA RESEARCH (2004)
Leukocyte elastase and autoantibodies to nerve growth factor in the acute phase of schizophrenia and their relationship to symptomatology
IV Shcherbakova et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2004)
Linkage and linkage disequilibrium of evoked EEG oscillations with CHRM2 receptor gene polymorphisms:: implications for human brain dynamics and cognition
KA Jones et al.
INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY (2004)
Rheumatoid arthritis and schizophrenia: a negative association at a dimensional level
P Gorwood et al.
SCHIZOPHRENIA RESEARCH (2004)
Th1, Th2 and Th3 cytokine alteration in schizophrenia
YK Kim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia
H Silver
EXPERT OPINION ON PHARMACOTHERAPY (2004)
Decreased plasma antioxidants in schizophrenia
P Chi-Un et al.
NEUROPSYCHOBIOLOGY (2004)
Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype
DL Garver et al.
NEUROPSYCHOPHARMACOLOGY (2003)
White matter changes in schizophrenia - Evidence for myelin-related dysfunction
KL Davis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
The neurodevelopmental hypothesis of schizophrenia: a review of recent developments
JJ McGrath et al.
ANNALS OF MEDICINE (2003)
Analysis of a polymorphism in the promoter region of the tumor necrosis factor alpha gene in schizophrenia and bipolar disorder: further support for an association with schizophrenia
IV Meira-Lima et al.
MOLECULAR PSYCHIATRY (2003)
Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology
XY Zhang et al.
SCHIZOPHRENIA RESEARCH (2002)
Cytokines, stress, and depressive illness
H Anisman et al.
BRAIN BEHAVIOR AND IMMUNITY (2002)
Serological observations in patients suffering from acute manic episodes
AA Wadee et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2002)
Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor
M Maes et al.
SCHIZOPHRENIA RESEARCH (2002)
The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs
YK Kim et al.
MOLECULAR PSYCHIATRY (2002)
Leukocytosis and hypoalbuminemia in mixed bipolar states: evidence for immune activation
F Cassidy et al.
ACTA PSYCHIATRICA SCANDINAVICA (2002)
Interferon-alpha, cytokines and possible implications for mood disorders
M Schaefer et al.
BIPOLAR DISORDERS (2002)
Immune activation, steroid resistancy and bipolar disorder
RW Kupka et al.
BIPOLAR DISORDERS (2002)
The Th2-hypothesis of schizophrenia:: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms
MJ Schwarz et al.
MEDICAL HYPOTHESES (2001)
Tumour necrosis factor α and bipolar affective puerperal psychosis
F Middle et al.
PSYCHIATRIC GENETICS (2000)
Epidemiology of schizophrenia: the global burden of disease and disability
A Jablensky
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2000)
Cytokine production in chorioamnionitis
F Saji et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2000)
Interleukin-6 and tumor necrosis factor-α production after acute psychological stress, exercise, and infused isoproterenol:: Differential effects and pathways
MU Goebel et al.
PSYCHOSOMATIC MEDICINE (2000)
Cytokines and the brain: Implications for clinical psychiatry
Z Kronfol et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Decreased levels of soluble intercellular adhesion molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients
MJ Schwarz et al.
BIOLOGICAL PSYCHIATRY (2000)
分享论文
